Cargando…
Chagasic patients are able to respond against a viral antigen from influenza virus
BACKGROUND: Trypanosoma cruzi, the etiological agent of Chagas’ disease, is an obligate intracellular parasite which induces a CD8(+) T cell immune response with secretion of cytokines and release of cytotoxic granules. Although an immune-suppressive effect of T. cruzi on the acute phase of the dise...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511223/ https://www.ncbi.nlm.nih.gov/pubmed/22920436 http://dx.doi.org/10.1186/1471-2334-12-198 |
_version_ | 1782251559785070592 |
---|---|
author | Lasso, Paola Mesa, Diana Bolaños, Natalia Cuéllar, Adriana Guzmán, Fanny Cucunuba, Zulma Rosas, Fernando Velasco, Víctor Thomas, Maria C López, Manuel Carlos González, John Mario Puerta, Concepción Judith |
author_facet | Lasso, Paola Mesa, Diana Bolaños, Natalia Cuéllar, Adriana Guzmán, Fanny Cucunuba, Zulma Rosas, Fernando Velasco, Víctor Thomas, Maria C López, Manuel Carlos González, John Mario Puerta, Concepción Judith |
author_sort | Lasso, Paola |
collection | PubMed |
description | BACKGROUND: Trypanosoma cruzi, the etiological agent of Chagas’ disease, is an obligate intracellular parasite which induces a CD8(+) T cell immune response with secretion of cytokines and release of cytotoxic granules. Although an immune-suppressive effect of T. cruzi on the acute phase of the disease has been described, little is known about the capacity of CD8(+) T cell from chronic chagasic patients to respond to a non-T. cruzi microbial antigen. METHODS: In the present paper, the frequency, phenotype and the functional activity of the CD8(+) T cells specific from Flu-MP*, an influenza virus epitope, were determined in 13 chagasic patients and 5 healthy donors. RESULTS: The results show that Flu-MP* peptide specific CD8(+) T cells were found with similar frequencies in both groups. In addition, Flu-MP* specific CD8(+) T cells were distributed in the early or intermediate/late differentiation stages without showing enrichment of a specific sub-population. The mentioned Flu-MP* specific CD8(+) T cells from chagasic patients were predominately T(EM) (CCR7- CD62L-), producing IL-2, IFNγ, CD107a/b and perforin, and did not present significant differences when compared with those from healthy donors. CONCLUSIONS: Our results support the hypothesis that there is no CD8(+) T cell nonspecific immune-suppression during chronic Chagas disease infection. Nonetheless, other viral antigens must be studied in order to confirm our findings. |
format | Online Article Text |
id | pubmed-3511223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35112232012-12-01 Chagasic patients are able to respond against a viral antigen from influenza virus Lasso, Paola Mesa, Diana Bolaños, Natalia Cuéllar, Adriana Guzmán, Fanny Cucunuba, Zulma Rosas, Fernando Velasco, Víctor Thomas, Maria C López, Manuel Carlos González, John Mario Puerta, Concepción Judith BMC Infect Dis Research Article BACKGROUND: Trypanosoma cruzi, the etiological agent of Chagas’ disease, is an obligate intracellular parasite which induces a CD8(+) T cell immune response with secretion of cytokines and release of cytotoxic granules. Although an immune-suppressive effect of T. cruzi on the acute phase of the disease has been described, little is known about the capacity of CD8(+) T cell from chronic chagasic patients to respond to a non-T. cruzi microbial antigen. METHODS: In the present paper, the frequency, phenotype and the functional activity of the CD8(+) T cells specific from Flu-MP*, an influenza virus epitope, were determined in 13 chagasic patients and 5 healthy donors. RESULTS: The results show that Flu-MP* peptide specific CD8(+) T cells were found with similar frequencies in both groups. In addition, Flu-MP* specific CD8(+) T cells were distributed in the early or intermediate/late differentiation stages without showing enrichment of a specific sub-population. The mentioned Flu-MP* specific CD8(+) T cells from chagasic patients were predominately T(EM) (CCR7- CD62L-), producing IL-2, IFNγ, CD107a/b and perforin, and did not present significant differences when compared with those from healthy donors. CONCLUSIONS: Our results support the hypothesis that there is no CD8(+) T cell nonspecific immune-suppression during chronic Chagas disease infection. Nonetheless, other viral antigens must be studied in order to confirm our findings. BioMed Central 2012-08-24 /pmc/articles/PMC3511223/ /pubmed/22920436 http://dx.doi.org/10.1186/1471-2334-12-198 Text en Copyright ©2012 Lasso et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lasso, Paola Mesa, Diana Bolaños, Natalia Cuéllar, Adriana Guzmán, Fanny Cucunuba, Zulma Rosas, Fernando Velasco, Víctor Thomas, Maria C López, Manuel Carlos González, John Mario Puerta, Concepción Judith Chagasic patients are able to respond against a viral antigen from influenza virus |
title | Chagasic patients are able to respond against a viral antigen from influenza virus |
title_full | Chagasic patients are able to respond against a viral antigen from influenza virus |
title_fullStr | Chagasic patients are able to respond against a viral antigen from influenza virus |
title_full_unstemmed | Chagasic patients are able to respond against a viral antigen from influenza virus |
title_short | Chagasic patients are able to respond against a viral antigen from influenza virus |
title_sort | chagasic patients are able to respond against a viral antigen from influenza virus |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511223/ https://www.ncbi.nlm.nih.gov/pubmed/22920436 http://dx.doi.org/10.1186/1471-2334-12-198 |
work_keys_str_mv | AT lassopaola chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT mesadiana chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT bolanosnatalia chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT cuellaradriana chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT guzmanfanny chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT cucunubazulma chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT rosasfernando chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT velascovictor chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT thomasmariac chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT lopezmanuelcarlos chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT gonzalezjohnmario chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus AT puertaconcepcionjudith chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus |